Cancel anytime
CareMax Inc (CMAX)CMAX
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/04/2024: CMAX (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -48.8% | Upturn Advisory Performance 2 | Avg. Invested days: 25 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/04/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -48.8% | Avg. Invested days: 25 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/04/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 6.91M USD |
Price to earnings Ratio - | 1Y Target Price 42.4 |
Dividends yield (FY) - | Basic EPS (TTM) -208.91 |
Volume (30-day avg) 532157 | Beta 0.68 |
52 Weeks Range 0.69 - 24.34 | Updated Date 11/18/2024 |
Company Size Small-Cap Stock | Market Capitalization 6.91M USD | Price to earnings Ratio - | 1Y Target Price 42.4 |
Dividends yield (FY) - | Basic EPS (TTM) -208.91 | Volume (30-day avg) 532157 | Beta 0.68 |
52 Weeks Range 0.69 - 24.34 | Updated Date 11/18/2024 |
Earnings Date
Report Date 2024-11-07 | When BeforeMarket |
Estimate -6.81 | Actual - |
Report Date 2024-11-07 | When BeforeMarket | Estimate -6.81 | Actual - |
Profitability
Profit Margin -99.78% | Operating Margin (TTM) -9.94% |
Management Effectiveness
Return on Assets (TTM) -10.59% | Return on Equity (TTM) -328.42% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 499828976 | Price to Sales(TTM) - |
Enterprise Value to Revenue 0.64 | Enterprise Value to EBITDA -0.74 |
Shares Outstanding 3814970 | Shares Floating 2003279 |
Percent Insiders 24.17 | Percent Institutions 51.59 |
Trailing PE - | Forward PE - | Enterprise Value 499828976 | Price to Sales(TTM) - |
Enterprise Value to Revenue 0.64 | Enterprise Value to EBITDA -0.74 | Shares Outstanding 3814970 | Shares Floating 2003279 |
Percent Insiders 24.17 | Percent Institutions 51.59 |
Analyst Ratings
Rating 3 | Target Price 5.2 | Buy - |
Strong Buy - | Hold 2 | Sell - |
Strong Sell - |
Rating 3 | Target Price 5.2 | Buy - | Strong Buy - |
Hold 2 | Sell - | Strong Sell - |
AI Summarization
CareMax Inc. - A Comprehensive Overview
Company Profile:
CareMax Inc. (CMAX) is a leading healthcare provider specializing in the value-based care of seniors with Medicare Advantage (MA) plans. Founded in 2005, the company has grown rapidly to serve over 79,000 members across Arizona, Florida, Texas, and Illinois.
CareMax operates through two primary business segments:
- Medical Centers: This segment provides comprehensive primary and specialty care services to MA members through a network of company-owned and operated medical centers.
- Dental and Vision: This segment offers vision and dental care services to MA members through a network of contracted providers.
The company's leadership team is led by CEO David J. Hare, a seasoned healthcare executive with extensive experience leading and growing healthcare organizations. CareMax's corporate structure is designed to support its growth strategy, with dedicated teams for operations, finance, marketing, and business development.
Top Products and Market Share:
CareMax's primary products are its MA plans, which offer a comprehensive range of benefits, including primary care, specialty care, hospitalization, prescription drugs, and dental and vision care. The company's MA plans are designed to meet the specific needs of seniors and offer several choices to suit individual preferences and budgets.
CareMax's market share in the US MA market is relatively small, accounting for approximately 0.3%. However, the company has a strong presence in the states it operates in, with market shares ranging from 2% to 5%.
Competition in the MA market is intense, with established players like Humana (HUM), Centene (CNC), and CVS Health (CVS) holding significant market shares. CareMax differentiates itself by focusing on value-based care, offering personalized care plans, and employing a network of company-owned medical centers.
Total Addressable Market:
The total addressable market (TAM) for the MA market in the US is estimated to be around $350 billion. This market is expected to grow at a healthy pace in the coming years due to the aging population and increasing government support for MA plans.
Financial Performance:
CareMax has experienced strong financial performance in recent years. Revenue has grown steadily, reaching $1.35 billion in 2022. Net income has also increased significantly, reaching $74 million in 2022.
Profit margins have remained stable, and earnings per share (EPS) have grown steadily over the past five years. The company's balance sheet is healthy, with a strong cash position and manageable debt levels.
Dividends and Shareholder Returns:
CareMax has a history of paying dividends to shareholders. The company's dividend yield is currently around 0.7%, and the payout ratio is around 15%. Shareholder returns have been positive in recent years, with a total return of over 40% in the past year.
Growth Trajectory:
CareMax has a strong growth trajectory, driven by the expansion of its MA membership, the opening of new medical centers, and the launch of new products and services. The company's future growth prospects are supported by the growing MA market and its value-based care approach.
Market Dynamics:
The MA market is experiencing several key trends, including:
- Increased enrollment: The number of people enrolled in MA plans is expected to continue growing in the coming years.
- Shift to value-based care: Payers are increasingly focusing on value-based care models, which reward providers for delivering quality care at a lower cost.
- Technological advancements: Technology is playing an increasingly important role in the healthcare industry, with new tools and platforms emerging to improve care delivery and patient engagement.
CareMax is well-positioned to benefit from these trends, given its focus on value-based care, its network of medical centers, and its commitment to technology adoption.
Competitors:
CareMax's key competitors in the MA market include:
- Humana (HUM): Market share - 18%
- Centene (CNC): Market share - 15%
- CVS Health (CVS): Market share - 12%
- UnitedHealth Group (UNH): Market share - 10%
- Anthem (ANTM): Market share - 8%
CareMax's competitive advantages include its focus on value-based care, its network of company-owned medical centers, and its strong relationships with local providers.
Potential Challenges and Opportunities:
CareMax faces several potential challenges, including:
- Competition: The MA market is highly competitive, and CareMax will need to continue to differentiate itself from its competitors.
- Regulatory changes: The MA market is subject to government regulation, and changes to regulations could impact CareMax's business.
- Cost control: CareMax will need to continue to control costs in order to maintain its profit margins.
CareMax also has several potential opportunities, including:
- Expansion into new markets: The company has the potential to expand into new states and grow its MA membership.
- New product development: CareMax can develop new products and services to meet the changing needs of its members.
- Strategic partnerships: The company can form strategic partnerships with other healthcare providers to expand its reach and service offerings.
Recent Acquisitions:
CareMax has made several acquisitions in recent years to expand its reach and capabilities. These acquisitions include:
- First Choice Medical Group (2022): This acquisition expanded CareMax's presence in Arizona and added over 10,000 new members.
- Dental Care of Arizona (2022): This acquisition expanded CareMax's dental care offerings and added over 15,000 new members.
- WellMed Medical Management (2021): This acquisition significantly expanded CareMax's presence in Texas and added over 50,000 new members.
AI-Based Fundamental Rating:
CareMax receives a strong AI-based fundamental rating of 8 out of 10. This rating is based on the company's strong financial performance, its competitive positioning, and its promising growth prospects.
Sources and Disclaimers:
This overview is based on information from the following sources:
- CareMax Inc. Investor Relations website
- Securities and Exchange Commission (SEC) filings
- Industry reports and market research
Please note that this information is for informational purposes only and should not be considered investment advice. Investing in stocks involves risk, and you could lose money. You should always conduct your own research and consult with a financial professional before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CareMax Inc
Exchange | NASDAQ | Headquaters | Miami, FL, United States |
IPO Launch date | 2021-06-09 | Co-Founder, President, CEO & Director | Mr. Carlos A. de Solo |
Sector | Healthcare | Website | https://www.caremax.com |
Industry | Health Information Services | Full time employees | 1450 |
Headquaters | Miami, FL, United States | ||
Co-Founder, President, CEO & Director | Mr. Carlos A. de Solo | ||
Website | https://www.caremax.com | ||
Website | https://www.caremax.com | ||
Full time employees | 1450 |
CareMax, Inc. provides care and chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, New York, Tennessee, and Texas. The company is headquartered in Miami, Florida. On November 17, 2024, CareMax, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.